House lawmaker raises new concerns over FDA’s ultra-fast drug review program

A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...
STAT

FDA Commissioner Marty Makary tries to soothe staff concerns over voucher program

At an employee town hall, FDA leaders tried to quell staff concerns about a controversial new program to fast-track certain ...

FDA commissioner explains new labeling guidelines for dyes on food packages

FDA Commissioner Dr. Marty Makary reveals new guidelines for food packaging labels on products with natural dyes.
Fierce Pharma

FDA's Makary pledges crackdown on mass marketing of 'illegal copycat drugs' in wake of Hims' Wegovy pill push

With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the ...

Hims shares plunge after FDA threatens action on 'illegal copycat drugs'

By Carlos Méndez and Chris Thomas Feb 5 (Reuters) - The U.S. Food and Drug Administration (FDA) will take swift action ...
BioSpace

FDA’s Commissioner’s Priority Voucher Program ‘Shrouded in Secrecy,’ Democratic Rep Says

Rep. Jake Auchincloss of Massachusetts said the Commissioner’s National Priority Voucher program did not receive congressional backing. The FDA has also not yet made disclosures for eight senior ...

FDA eases food dye enforcement on labels

The Food and Drug Administration said Thursday that it will not enforce regulations against "false or misleading" material on ...

Politicization runs deeper than ever at FDA, risking long-term impacts

Wide-ranging shifts at the FDA have set the stage for decisions that drag the agency through the political mud, according to ...

List of Foods, Drinks That Can Claim ‘No Artificial Colors’ After FDA Shift

The FDA specifically approved beetroot red and expanded the permitted uses of spirulina extract for blues and greens to color ...
STAT

Pharmalittle: We’re reading about worries over FDA voucher program, a new U.S. Novo exec, and more

FDA leaders tried to quell concerns about a controversial new program to fast-track certain drugs at an employee town hall ...